Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines
Clinical trial NCT05766683 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05766683
- Sponsor
- Henry Ford Health System
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2023-06-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.